The Liver Meeting 2011

[ytdthjznyj]

http://onlinelibrary.wiley.com/doi/10.1002/hep.v54.1s/issuetoc

[StephenCastlecrag]

I don't think it is very expensive, but you have to stay in hospital for the drip. It does not cure, it just lowers ALT, temporarily, from what I can gather. Just have to wait and see.

[stef2011]

there is an austrian companu making infusion silymarin, it has very potent antiviral effect on hcv but the price is about 13000euro
although it has to be proven an antiviral effect might work on hbv too since it is extremely unlikly silymarin targets viruses.i suppose it targets antioxidations pathways and maybe methylation pathways which are known to silent viruses.oxidative stress is raised by hbx protein in hbv and is essential to hbv cronic infection for effect on host.like hbeag it is not a constitents of hbv virions

who knows they are just making advantage of sick people, do you know the cost in china?

[StephenCastlecrag]

The President of AASLD will preview 10 papers before the start of Liver meeting. Unfortunately, no HBV paper is included. However, one of the papers  is the result of a clinical trial testing silymarin (Milk Thistle) on HCV. This paper may be of interest to HBV, because silymarin by infusion is used often in China to lower ALT and seems to be effective. It seems taking silymarin orally is not enough to get the high dosage of silymarin required to work. The Chinese patients usually go to hospital to get silymarin (and other herbal stuff) by infusion.

All these are just my own speculation, so wait till we see the paper.

[StephenCastlecrag]

You have to be a member of AASLD or subscriber to Hepatology to login.  I think this year the Liver meeting will be dominated by new treatments for HCV. This is just my feeling. Still, I am hoping for surprises. Apparently, the single-topic Liver meeting in Beijing had no exciting news. Certainly no news on the Chinese therapeutic vaccine.

[stef2011]

ytdthjznyj
StephenCastlecrag

anyway to get in?

http://aasld2011.abstractcentral.com/login

[stef2011]

i dont expect many news on hbv in US due to patents exp on 2015-2017 (europe and asia meeting have usually best data), which dates can we see something about posters?

[StephenCastlecrag]

There is an embargo on. studyforhope had given us a look at the paper on REP 9AC already.